Posted in | News | Nanomedicine

Tantalum Oxide Nano-Particles for CT Scans

Researchers have developed a process to mass manufacture an imaging agent to be used in computed tomography (CT) scans in heart disease, and breast cancer. Tantalum oxide is a cost-effective nanoparticle, which remains in the body until it has captured multiple organ images. The report has been published in the Journal of the American Chemical Society.

According to the team led by Taeghwan Hyeon and Seung Hong Choi, CT involves medical imaging tests in diagnosing diseases. But it needs large quantities of agents that can render body organs visible.

Large quantities of tantalum oxide nanoparticles have been developed and clinically tested in the heart, lymph nodes and kidneys in lab rats. The nanoparticles were found not to impact normal organ functioning. They could be used in monitoring blood vessels in the heart to detect blockages, and lymph nodes to detect breast cancer.

The research program has been funded by the Korean Ministry of Education, Science, and Technology, besides the National Research Foundation of Korea.

Source: http://pubs.acs.org

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    American Chemical Society. (2019, February 12). Tantalum Oxide Nano-Particles for CT Scans. AZoNano. Retrieved on December 03, 2023 from https://www.azonano.com/news.aspx?newsID=22362.

  • MLA

    American Chemical Society. "Tantalum Oxide Nano-Particles for CT Scans". AZoNano. 03 December 2023. <https://www.azonano.com/news.aspx?newsID=22362>.

  • Chicago

    American Chemical Society. "Tantalum Oxide Nano-Particles for CT Scans". AZoNano. https://www.azonano.com/news.aspx?newsID=22362. (accessed December 03, 2023).

  • Harvard

    American Chemical Society. 2019. Tantalum Oxide Nano-Particles for CT Scans. AZoNano, viewed 03 December 2023, https://www.azonano.com/news.aspx?newsID=22362.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit